ARGOS THERAPEUTICS INC: 10-Q filed 2016-11-14

Name: ARGOS THERAPEUTICS INC: 10-Q filed 2016-11-14
Creator: ARGOS THERAPEUTICS INC

What ARGOS THERAPEUTICS INC reported in its quarterly report filed 2016-11-14 (fiscal Q3 2016): 30 published measures, 79 facts as tagged in accession 0001171843-16-013204.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-11-14
Fiscal period: fiscal Q3 2016
Accession: 0001171843-16-013204 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ARGOS THERAPEUTICS INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	108,770,057	USD
At 2015-12-31	31,037,699	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-09-30	20,134,929	USD
At 2015-12-31	-28,201,435	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-09-30	69,283,934	USD
At 2015-12-31	6,163,144	USD
At 2015-09-30	20,037,679	USD
At 2014-12-31	37,223,590	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-12,246,841	USD	92
2016-01-01 to 2016-09-30	-37,673,274	USD	274
2015-07-01 to 2015-09-30	-20,078,568	USD	92
2015-01-01 to 2015-09-30	-57,229,601	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	10,037,447	USD	274
2015-01-01 to 2015-09-30	7,709,337	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	146,756	USD	92
2016-01-01 to 2016-09-30	781,828	USD	274
2015-07-01 to 2015-09-30	158,349	USD	92
2015-01-01 to 2015-09-30	444,511	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-09-30	-316,631,981	USD
At 2015-12-31	-278,958,707	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	0	USD	274

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-09-30	37,489,337	USD
At 2015-12-31	22,306,384	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	3,759,947	USD	274
2015-01-01 to 2015-09-30	2,860,867	USD	273

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-12,203,780	USD	92
2016-01-01 to 2016-09-30	-36,599,371	USD	274
2015-07-01 to 2015-09-30	-19,758,454	USD	92
2015-01-01 to 2015-09-30	-55,604,667	USD	273

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-09-30	71,269,700	USD
At 2015-12-31	8,720,295	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	448,288	USD	92
2016-01-01 to 2016-09-30	1,482,943	USD	274
2015-07-01 to 2015-09-30	324,871	USD	92
2015-01-01 to 2015-09-30	1,645,308	USD	273

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-09-30	23,933,688	USD
At 2015-12-31	8,162,813	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-09-30	3,567,440	USD
At 2015-12-31	2,907,683	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	12,350,536	USD	92
2016-01-01 to 2016-09-30	37,381,199	USD	274
2015-07-01 to 2015-09-30	19,916,803	USD	92
2015-01-01 to 2015-09-30	56,049,178	USD	273

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	9,340,018	USD	92
2016-01-01 to 2016-09-30	28,006,178	USD	274
2015-07-01 to 2015-09-30	17,227,405	USD	92
2015-01-01 to 2015-09-30	48,079,221	USD	273

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-09-30	41,243,314	shares
At 2015-12-31	21,641,509	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-09-30	336,856,362	USD
At 2015-12-31	250,873,875	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2016-09-30	-130,695	USD
At 2015-12-31	-138,245	USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

Period	Value	Unit	Days
At 2016-09-30	31,500,000	USD
At 2015-12-31	32,400,000	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2016-09-30	46,946,404	USD
At 2015-12-31	31,150,719	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-09-30	9,457,067	USD
At 2015-12-31	8,844,335	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2016-09-30	11,020	USD
At 2015-12-31	11,020	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2016-09-30	7,457,958	USD
At 2015-12-31	3,676,846	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2016-09-30	1,126,509	USD
At 2015-12-31	740,173	USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	3,010,518	USD	92
2016-01-01 to 2016-09-30	9,375,021	USD	274
2015-07-01 to 2015-09-30	2,689,398	USD	92
2015-01-01 to 2015-09-30	7,969,957	USD	273

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	257,992	USD	92
2016-01-01 to 2016-09-30	697,730	USD	274
2015-07-01 to 2015-09-30	171,064	USD	92
2015-01-01 to 2015-09-30	519,026	USD	273

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-43,061	USD	92
2016-01-01 to 2016-09-30	-1,073,903	USD	274
2015-07-01 to 2015-09-30	-320,114	USD	92
2015-01-01 to 2015-09-30	-1,624,934	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-270,890	USD	274
2015-01-01 to 2015-09-30	566,066	USD	273

Inspect the source

Entity: ARGOS THERAPEUTICS INC / CIK 0001105533
Captured: 2026-09-22 19:39 UTC
SEC response SHA-256: 07ee84a7b42518f1df0d6d45cc8782b7755c6cd7cd844b2cc13a94f0396ce00f

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001105533.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))